The Rohringer Lab is a research unit at the Medical University of Vienna that focuses on improving the performance of cardiovascular implants. The goal of our work is to translate knowledge from basic research into translational approaches using new scientific methods. We place particular emphasis on supporting early-career researchers and ensuring clinical relevance.
Mission and Vision
The Rohringer Lab is a research unit of the Medical University of Vienna dedicated to improving the healing, safety and long-term function of cardiovascular implants. Our research focuses on the interaction between biomaterials, vascular cells and the perivascular adipose tissue surrounding the vessels. We investigate how this adipose tissue influences inflammatory reactions, vascular healing and tissue remodeling after implantation and what role cellular signaling pathways and extracellular vesicles play in this. On this basis, we develop targeted therapeutic and biomaterial-based approaches to promote a favorable local tissue environment and thus sustainably improve the integration of implants.
Our goal is to consistently translate findings from basic research into clinically relevant, translational solutions. To this end, we develop and use innovative in vitro models, including cell culture, co-culture, and biomaterial-based test systems, to precisely investigate the interaction of implant materials with endothelial cells, smooth muscle cells, and fat cells. The insights gained should not only provide new starting points for improving existing cardiovascular implants, but also support the development of future bioactive and immunomodulating biomaterials. At the same time, we see the promotion of young scientists as a central component of our mission: We create an interdisciplinary research environment that combines methodological excellence, clinical relevance, and the training of future scientists.
Historie
After successfully completing her PhD and 3 years of postdoc experience in the former Bergmeister Lab, Sabrina Rohringer founded the new lab in 2026 with new research approaches.